A phase III trial of PPP001 (smokeable marijuana) in terminal cancer patients
Phase of Trial: Phase III
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Marijuana (Primary)
- Indications Cancer pain; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Tetra Bio Pharma
- 18 Sep 2017 According to a Tetra Bio Pharma media release, the company will be filing a clinical trial application (CTA) in the coming weeks to therapeutic products directorate (TPD) to initiate this phase III clinical trial of PPP001 in terminal cancer patients.
- 15 Jun 2017 New trial record
- 07 Jun 2017 According to a Tetra Bio-Pharma media release, the company expects to launch this trial in collaboration with Quebec's leading medical cannabis clinic, Sante Cannabis by the fourth quarter of 2017 or first quarter of 2018. Dr. Antonio Vigano, will be the lead trial physician.